IDEXX Laboratories/ US45168D1046 /
| 2024-05-02 9:59:55 PM | Chg. +7.95 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 475.95USD | +1.70% | 20,951 Turnover: 9.92 mill. |
-Bid Size: - | -Ask Size: - | 39.3 bill.USD | - | 46.79 |
Assets
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 216.8000 | 245.2000 | 281.2000 | 303.5870 | 333.0260 | ||||||
| Intangible Assets | 69.2000 | 62.8000 | 58.8000 | 65.1220 | 55.9090 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | 624.8130 | 653.3590 | ||||||
| Inventories | 133.1000 | 140.9000 | 133.4000 | 160.3420 | 188.8330 | ||||||
| Accounts Receivable | 141.3000 | 138.3000 | 158 | 152.3800 | 188.3180 | ||||||
| Cash and Cash Equivalents | 183.9000 | 224 | 279.1000 | 322.5360 | 128.9940 | ||||||
| Current Assets | 524.2000 | 569.5000 | 652.7000 | 759.3980 | 821.6340 | ||||||
| Total Assets | 1,030.8000 | 1,103.6000 | 1,230.5000 | 1,384.2110 | 1,474.9930 | ||||||
Liabilities
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 36.6000 | 35.3000 | 29.9000 | 44.7430 | 52.6480 | ||||||
| Long-term debt | - | - | - | 350 | 597.0850 | ||||||
| Liabilities to Banks | 243 | 212 | 277 | 549 | 573 | ||||||
| Provisions | 141.4000 | 137.7000 | 148.9000 | 195.4000 | 205.5000 | ||||||
| Liabilities | 491.2000 | 467.3000 | 712.3000 | 1,266.6220 | 1,558.9880 | ||||||
| Share Capital | 9.9000 | 10 | 10.1190 | 20.3900 | 10.2580 | ||||||
| Total Equity | 539.6000 | 636.3000 | 518.2000 | 117.5890 | -83.9950 | ||||||
| Minority Interests | 0.0000 | 0.0000 | .0300 | .0730 | .1300 | ||||||
| Total liabilities equity | 1,030.8000 | 1,103.6000 | 1,230.5000 | 1,384.2110 | 1,474.9930 | ||||||
Income Statement
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,218.7000 | 1,293.3000 | 1,377.1000 | 1,485.8070 | 1,601.8920 | ||||||
| Depreciation (total) | - | - | - | 58.8880 | 68.9560 | ||||||
| Operating Result | 236.2000 | 262.6000 | 266.8000 | 260.2550 | 299.9120 | ||||||
| Interest Income | -1.8000 | -1.9000 | -3.5000 | -13.7000 | -26.7710 | ||||||
| Income Before Taxes | 234.4000 | 260.6000 | 263.3000 | 246.5550 | 273.1410 | ||||||
| Income Taxes | 72.7000 | 82.3000 | 75.5000 | 64.6040 | 81.0060 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | .0450 | .0570 | ||||||
| Net Income | 161.8000 | 178.3000 | 187.8000 | 181.9060 | 192.0780 | ||||||
Per Share
Cash Flow
| 2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 220.7000 | 230.3000 | 246 | 235.8460 | 216.3640 | ||||||
| Cash Flow from Investing Activities | -97 | -66 | -86.1000 | -80.4130 | -308.4060 | ||||||
| Cash Flow from Financing | -97.7000 | -125.3000 | -102.5000 | -103.4380 | -95.5520 | ||||||
| Decrease / Increase in Cash | 27 | 40.1000 | 55.1000 | 43.4780 | -193.5420 | ||||||
| Employees | 5,100 | 5,400 | 5,700 | 6,400 | 6,800 | ||||||
